A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b (clinicaltrials.gov) - Sep 30, 2026 - P2 | N=17 | Completed | Sponsor: Alaunos Therapeutics | Unknown status ➔ Completed
Trial completion • Hematological Malignancies • Multiple Myeloma • Oncology
|